| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/19/2001 | WO2001026678A1 Short segments of dap-kinase |
| 04/19/2001 | WO2001026677A1 Interferon complex and medicinal use thereof |
| 04/19/2001 | WO2001026674A2 Method for treating otic disorders |
| 04/19/2001 | WO2001026658A2 Topical nasal treatment using desloratadine |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026648A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | US20010000345 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 04/19/2001 | CA2387541A1 Short segments of dap-kinase |
| 04/19/2001 | CA2387535A1 Substituted imidazolidinone derivatives |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387205A1 Interferon complex and pharmaceutical use thereof |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2386177A1 Oculomedin and glaucoma |
| 04/19/2001 | CA2383970A1 Topical nasal treatment using desloratadine |
| 04/19/2001 | CA2382937A1 Anhydrous salt |
| 04/18/2001 | EP1091746A1 Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions |
| 04/18/2001 | EP1091736A1 Inhibitors of prenyl-protein transferase |
| 04/18/2001 | EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 04/18/2001 | EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 04/18/2001 | CN1291976A Indole ferivatives and medicinal compositions containing same |
| 04/18/2001 | CN1291898A Remedies for corneal epithelium disturbance |
| 04/18/2001 | CN1291500A Chinese patent medicine for treating myopia and amblyopia |
| 04/18/2001 | CN1291495A Health-care vision-improving tea |
| 04/18/2001 | CN1064549C Chinese medicinal pills for treating catarct and its prodn. method |
| 04/17/2001 | US6218528 MurB |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218415 Therapy of bone reabsorption by osteoclasts, tumor growth and tumor metastasis, inflammation, cardiovascular disease, nephropathies and retinopathies |
| 04/17/2001 | US6218390 Morpholinone and morpholine derivatives and uses thereof |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218385 1,2,4,5-Tetrahydro-benzo[D]azepin derivatives |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6217895 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025239A2 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/12/2001 | WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024797A1 Integrin receptor antagonists |
| 04/12/2001 | WO2000069426A3 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 04/12/2001 | WO2000066144A3 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections |
| 04/12/2001 | WO2000064425A3 Miotic agents and hypertonic agents containing ophthalmic compositions |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2386030A1 Integrin receptor antagonists |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2382691A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090915A1 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[-4-(methylsulfonyl)phenyl]- 5,5-dimethyl-5H-furan-2-one |
| 04/11/2001 | EP1090105A1 Ependymal neural stem cells and method for their isolation |
| 04/11/2001 | EP1090012A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090011A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1089994A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1291100A Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents |
| 04/11/2001 | CN1290699A New pyrazolone compound and eye plastic lens made therefrom |
| 04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
| 04/11/2001 | CN1064249C Traditional Chinese medicine for treating nearsight |
| 04/10/2001 | US6214991 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-n-acetic acid, ethyl ester for example; treating complications of diabetes mellitus, such as cataracts, retinopathy, nephropathy, and neuropathy |
| 04/10/2001 | US6214876 Indene-1-acetamide sPLA2 inhibitors |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels |
| 04/10/2001 | US6214856 Treating neurodegenerative disorders, e.g., alzheimer's disease, strokes, traumatic brain injury; antiischemic agents; muscular dystrophy; also cataracts; platelet aggregation |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214346 Bactericides |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023399A1 Compounds for the treatment of ischemia |
| 04/05/2001 | WO2001023382A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
| 04/05/2001 | WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/05/2001 | WO2001023359A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/05/2001 | WO2001023347A1 Novel aromatic compounds |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022936A1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2001005397A8 Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having effective composition of the same |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000068198A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 04/05/2001 | WO2000064474A8 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 04/05/2001 | WO2000060051A8 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 04/05/2001 | WO2000057877A8 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 04/05/2001 | WO2000051547A3 Inhibitors of prenyl-protein transferase |
| 04/05/2001 | WO1996018391B1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |